CTSO: Cytosorbents Corp Financial Statements
Balance sheet, income statement, and cash flow statements for Cytosorbents Corp (CTSO).
$49.76M Market Cap.
CTSO Market Cap. (MRY)
CTSO Shares Outstanding (MRY)
CTSO Assets (MRY)
Total Assets
$47.37M
Total Liabilities
$36.26M
Total Investments
$0
CTSO Income (MRY)
Revenue
$35.59M
Net Income
-$20.72M
Operating Expense
$41.91M
CTSO Cash Flow (MRY)
CF Operations
-$14.43M
CF Investing
-$669.43K
CF Financing
$9.33M
CTSO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $47,371,500 (-10.55%) | $52,956,322 (-16.25%) | $63,231,530 (-29.37%) | $89,519,282 (-0.48%) |
Assets Current | $21,603,242 (-14.94%) | $25,398,511 (-24.77%) | $33,759,691 (-47.50%) | $64,298,890 (-22.02%) |
Assets Non-Current | $25,768,258 (-6.49%) | $27,557,811 (-6.49%) | $29,471,839 (16.86%) | $25,220,392 (236.39%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $11,106,936 (-52.70%) | $23,481,214 (-33.62%) | $35,374,973 (-43.47%) | $62,578,197 (-21.00%) |
Property Plant & Equipment Net | $20,513,619 (-7.24%) | $22,115,250 (-5.28%) | $23,346,933 (25.69%) | $18,574,358 (489.84%) |
Cash & Equivalents | $9,763,884 (-37.47%) | $15,615,095 (-34.48%) | $23,832,026 (-55.72%) | $53,825,166 (-24.64%) |
Accumulated Other Comprehensive Income | $4,252,013 (703.30%) | $529,321 (-77.27%) | $2,329,195 (343.16%) | $525,585 (130.31%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $2,732,907 (-19.04%) | $3,375,817 (-2.48%) | $3,461,586 (-27.37%) | $4,766,098 (78.25%) |
Trade & Non-Trade Receivables | $7,319,597 (20.84%) | $6,057,072 (6.92%) | $5,664,941 (25.24%) | $4,523,430 (-12.32%) |
Trade & Non-Trade Payables | $3,339,885 (-12.16%) | $3,802,170 (129.71%) | $1,655,173 (-41.00%) | $2,805,235 (52.87%) |
Accumulated Retained Earnings (Deficit) | -$304,008,618 (-7.31%) | -$283,289,661 (-11.53%) | -$253,997,878 (-14.83%) | -$221,185,295 (-12.49%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $26,440,321 (47.39%) | $17,939,516 (-1.12%) | $18,142,005 (36.91%) | $13,250,943 (2178.21%) |
Debt Current | $0 (0%) | $2,500,000 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $26,440,321 (71.25%) | $15,439,516 (-14.90%) | $18,142,005 (36.91%) | $13,250,943 (2178.21%) |
Total Liabilities | $36,264,564 (23.03%) | $29,475,108 (5.81%) | $27,856,557 (3.40%) | $26,941,085 (150.97%) |
Liabilities Current | $9,824,243 (-30.00%) | $14,035,592 (44.48%) | $9,714,552 (-29.04%) | $13,690,142 (34.84%) |
Liabilities Non-Current | $26,440,321 (71.25%) | $15,439,516 (-14.90%) | $18,142,005 (36.91%) | $13,250,943 (2178.21%) |
CTSO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $35,594,520 (14.51%) | $31,084,953 (-10.39%) | $34,688,809 (-19.64%) | $43,165,527 (5.27%) |
Cost of Revenue | $10,468,529 (14.64%) | $9,131,716 (-34.57%) | $13,955,752 (26.33%) | $11,047,350 (-0.05%) |
Selling General & Administrative Expense | $34,995,749 (-8.64%) | $38,307,415 (3.15%) | $37,136,029 (-3.50%) | $38,481,992 (22.12%) |
Research & Development Expense | $6,916,181 (-55.65%) | $15,594,442 (3.15%) | $15,118,907 (-7.70%) | $16,380,930 (85.92%) |
Operating Expenses | $41,911,930 (-22.24%) | $53,901,857 (3.15%) | $52,254,936 (-4.75%) | $54,862,922 (36.06%) |
Interest Expense | $1,399,092 (786.11%) | $157,891 (219.08%) | -$132,597 (-373.44%) | -$28,007 (-102.33%) |
Income Tax Expense | -$1,690,825 (-107.78%) | -$813,739 (25.52%) | -$1,092,585 (-48.45%) | -$736,003 (34.70%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$20,718,957 (29.16%) | -$29,246,760 (10.87%) | -$32,812,583 (-33.61%) | -$24,558,648 (-213.36%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$20,718,957 (29.16%) | -$29,246,760 (10.87%) | -$32,812,583 (-33.61%) | -$24,558,648 (-213.36%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$20,718,957 (29.16%) | -$29,246,760 (10.87%) | -$32,812,583 (-33.61%) | -$24,558,648 (-213.36%) |
Weighted Average Shares | $54,434,609 (21.90%) | $44,656,391 (2.49%) | $43,573,215 (0.49%) | $43,359,186 (11.70%) |
Weighted Average Shares Diluted | $54,434,609 (21.90%) | $44,656,391 (2.49%) | $43,573,215 (0.49%) | $43,359,186 (11.70%) |
Earning Before Interest & Taxes (EBIT) | -$21,010,690 (29.74%) | -$29,902,608 (12.15%) | -$34,037,765 (-34.42%) | -$25,322,658 (-226.19%) |
Gross Profit | $25,125,991 (14.45%) | $21,953,237 (5.89%) | $20,733,057 (-35.45%) | $32,118,177 (7.23%) |
Operating Income | -$16,785,939 (47.46%) | -$31,948,620 (-1.35%) | -$31,521,879 (-38.59%) | -$22,744,745 (-119.33%) |
CTSO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$669,430 (28.50%) | -$936,236 (85.50%) | -$6,455,576 (-50.79%) | -$4,281,261 (-155.41%) |
Net Cash Flow from Financing | $9,330,704 (-35.54%) | $14,474,210 (191.84%) | $4,959,642 (593.46%) | $715,199 (-98.92%) |
Net Cash Flow from Operations | -$14,427,809 (33.37%) | -$21,655,136 (23.30%) | -$28,234,282 (-101.59%) | -$14,005,599 (-149.51%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$5,851,211 (28.79%) | -$8,216,931 (72.60%) | -$29,993,140 (-70.45%) | -$17,596,435 (-129.73%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$284,343 (47.16%) | -$538,115 (91.16%) | -$6,087,365 (-67.18%) | -$3,641,248 (-414.01%) |
Issuance (Repayment) of Debt Securities | $10,000,000 (0%) | $0 (0%) | $5,000,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $178,654 (-98.77%) | $14,474,210 (35964.54%) | -$40,358 (-105.64%) | $715,199 (-99.12%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$84,676 (15.13%) | -$99,769 (62.05%) | -$262,924 (-961.29%) | -$24,774 (-119.00%) |
Share Based Compensation | $3,759,534 (-9.53%) | $4,155,342 (9.35%) | $3,800,091 (-38.75%) | $6,204,136 (31.79%) |
Depreciation Amortization & Accretion | $1,744,128 (-13.80%) | $2,023,422 (78.81%) | $1,131,629 (0.18%) | $1,129,613 (70.95%) |
CTSO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 70.60% (0.00%) | 70.60% (18.06%) | 59.80% (-19.62%) | 74.40% (1.92%) |
Profit Margin | -58.20% (38.15%) | -94.10% (0.53%) | -94.60% (-66.26%) | -56.90% (-197.91%) |
EBITDA Margin | -54.10% (39.69%) | -89.70% (5.48%) | -94.90% (-69.46%) | -56.00% (-223.70%) |
Return on Average Equity (ROAE) | -138.70% (-12.67%) | -123.10% (-66.58%) | -73.90% (-114.20%) | -34.50% (-125.49%) |
Return on Average Assets (ROAA) | -42.40% (23.74%) | -55.60% (-18.55%) | -46.90% (-76.98%) | -26.50% (-143.12%) |
Return on Sales (ROS) | -59.00% (38.67%) | -96.20% (1.94%) | -98.10% (-67.12%) | -58.70% (-210.58%) |
Return on Invested Capital (ROIC) | -41.40% (39.65%) | -68.60% (15.52%) | -81.20% (6.88%) | -87.20% (-68.99%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -2.4 (-40.22%) | -1.71 (17.37%) | -2.07 (71.88%) | -7.35 (81.55%) |
Price to Sales Ratio (P/S) | 1.39 (-12.73%) | 1.59 (-18.08%) | 1.95 (-53.74%) | 4.21 (-44.21%) |
Price to Book Ratio (P/B) | 4.48 (113.23%) | 2.1 (9.88%) | 1.91 (-34.32%) | 2.91 (-32.99%) |
Debt to Equity Ratio (D/E) | 3.27 (160.16%) | 1.25 (59.47%) | 0.79 (82.60%) | 0.43 (216.91%) |
Earnings Per Share (EPS) | -0.38 (41.54%) | -0.65 (13.33%) | -0.75 (-31.58%) | -0.57 (-185.00%) |
Sales Per Share (SPS) | 0.65 (-6.03%) | 0.7 (-12.56%) | 0.8 (-20.08%) | 1 (-5.68%) |
Free Cash Flow Per Share (FCFPS) | -0.27 (45.67%) | -0.5 (36.93%) | -0.79 (-93.61%) | -0.41 (-149.69%) |
Book Value Per Share (BVPS) | 0.2 (-61.22%) | 0.53 (-35.22%) | 0.81 (-43.73%) | 1.44 (-29.30%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.87 (-26.64%) | 1.19 (-18.26%) | 1.45 (-29.73%) | 2.06 (-10.88%) |
Enterprise Value Over EBIT (EV/EBIT) | -3 (-50.00%) | -2 (0.00%) | -2 (60.00%) | -5 (85.71%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.32 (-61.79%) | -2.05 (-19.72%) | -1.71 (69.17%) | -5.56 (85.48%) |
Asset Turnover | 0.73 (23.18%) | 0.59 (19.15%) | 0.5 (6.44%) | 0.47 (-18.25%) |
Current Ratio | 2.2 (21.49%) | 1.81 (-47.91%) | 3.48 (-26.02%) | 4.7 (-42.16%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$14,712,152 (33.71%) | -$22,193,251 (35.34%) | -$34,321,647 (-94.49%) | -$17,646,847 (-179.15%) |
Enterprise Value (EV) | $63,963,852 (11.82%) | $57,204,591 (1.42%) | $56,405,073 (-58.07%) | $134,506,061 (-50.55%) |
Earnings Before Tax (EBT) | -$22,409,782 (25.45%) | -$30,060,499 (11.34%) | -$33,905,168 (-34.04%) | -$25,294,651 (-182.17%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$19,266,562 (30.89%) | -$27,879,186 (15.28%) | -$32,906,136 (-36.01%) | -$24,193,045 (-240.63%) |
Invested Capital | $54,223,694 (31.47%) | $41,245,151 (-13.76%) | $47,826,957 (35.66%) | $35,254,917 (293.59%) |
Working Capital | $11,778,999 (3.66%) | $11,362,919 (-52.74%) | $24,045,139 (-52.49%) | $50,608,748 (-30.00%) |
Tangible Asset Value | $47,371,500 (-10.55%) | $52,956,322 (-16.25%) | $63,231,530 (-29.37%) | $89,519,282 (-0.48%) |
Market Capitalization | $49,758,408 (0.88%) | $49,326,745 (-27.07%) | $67,635,358 (-62.87%) | $182,162,965 (-47.06%) |
Average Equity | $14,942,638 (-37.11%) | $23,760,744 (-46.46%) | $44,376,069 (-37.68%) | $71,208,268 (38.89%) |
Average Assets | $48,918,227 (-7.02%) | $52,609,740 (-24.84%) | $69,994,604 (-24.38%) | $92,564,666 (28.69%) |
Invested Capital Average | $50,769,370 (16.48%) | $43,585,439 (3.96%) | $41,925,541 (44.44%) | $29,026,902 (92.96%) |
Shares | 54,679,569 (23.05%) | 44,438,509 (1.84%) | 43,635,715 (0.37%) | 43,475,648 (0.69%) |
